STADA is a leading manufacturer of high-quality medicines. With a long-standing tradition rooted in the pharmacy trade, it has been recognised as a reliable and trustworthy partner for 125 years. With its products, it helps people stay and become healthy and fit. With its proven generic products, it ensures that everyday health remains affordable and inexpensive. It offers its employees an attractive working environment in which they can develop personally.

STADA relies on a three-pillar strategy consisting of generics, special pharmaceuticals and non-prescription consumer healthcare products. STADA Arzneimittel AG sells its products in around 120 countries worldwide. Branded consumer healthcare products such as Zoflora®, Grippostad®, Snup®, Aqualor®, Vitaprost® and Nizoral® are among the top sellers in their respective product categories. In financial year 2020, STADA achieved Group sales of €3,010.3 million and adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) of €713.3 million. As of 31 December 2020, STADA employed 12,301 people worldwide.

You can find more information about STADA via this link here.